Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stauffer

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Haematology|October 27, 2007
The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotypeThomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, et al.
BMJ Case Reports|September 3, 2014
Primary CNS lymphoma in a patient treated with azathioprineMatilde Kanstrup Glesner, Lukas Frans Ocias, Thomas Stauffer Larsen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 21, 2007
Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemiaThomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, et al.
Critical Reviews in Oncology/Hematology|April 18, 2021
Prognostic models in primary central nervous system lymphoma patients: A systematic reviewJelena Jelicic, Thomas Stauffer Larsen, Zoran Bukumiric, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2022
Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic ReviewJelena Jelicic, Thomas Stauffer Larsen, Annette Dam Fialla, et al.
Critical Reviews in Oncology/Hematology|February 12, 2024
Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic reviewJelena Jelicic, Thomas Stauffer Larsen, Bosko Andjelic, et al.
Clinical Epidemiology|June 26, 2020
Statistical Challenges in Development of Prognostic Models in Diffuse Large B-Cell Lymphoma: Comparison Between Existing Models - A Systematic ReviewJelena Jelicic, Thomas Stauffer Larsen, Henrik Frederiksen, et al.
Hematology (Amsterdam, Netherlands)|January 22, 2009
Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burdenThomas Stauffer Larsen, Niels Pallisgaard, Karin de Stricker, et al.
Cancers|September 28, 2021
Harnessing the Immune System to Fight Multiple MyelomaJakub Krejcik, Mike Bogetofte Barnkob, Charlotte Guldborg Nyvold, et al.
Current Drug Targets|December 15, 2010
Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectivesHans Carl Hasselbalch, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Haematology|October 27, 2007
The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotypeThomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, et al.
BMJ Case Reports|September 3, 2014
Primary CNS lymphoma in a patient treated with azathioprineMatilde Kanstrup Glesner, Lukas Frans Ocias, Thomas Stauffer Larsen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 21, 2007
Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemiaThomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, et al.
Critical Reviews in Oncology/Hematology|April 18, 2021
Prognostic models in primary central nervous system lymphoma patients: A systematic reviewJelena Jelicic, Thomas Stauffer Larsen, Zoran Bukumiric, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2022
Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic ReviewJelena Jelicic, Thomas Stauffer Larsen, Annette Dam Fialla, et al.
Critical Reviews in Oncology/Hematology|February 12, 2024
Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic reviewJelena Jelicic, Thomas Stauffer Larsen, Bosko Andjelic, et al.
Clinical Epidemiology|June 26, 2020
Statistical Challenges in Development of Prognostic Models in Diffuse Large B-Cell Lymphoma: Comparison Between Existing Models - A Systematic ReviewJelena Jelicic, Thomas Stauffer Larsen, Henrik Frederiksen, et al.
Hematology (Amsterdam, Netherlands)|January 22, 2009
Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burdenThomas Stauffer Larsen, Niels Pallisgaard, Karin de Stricker, et al.
Cancers|September 28, 2021
Harnessing the Immune System to Fight Multiple MyelomaJakub Krejcik, Mike Bogetofte Barnkob, Charlotte Guldborg Nyvold, et al.
Current Drug Targets|December 15, 2010
Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectivesHans Carl Hasselbalch, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, et al.
Pageof 11